What this study is
Depression is a leading cause of disability worldwide and current treatments are ineffective for many people. This trial will investigate the efficacy of a 16-week high vs low dose resistance exercise training program for the treatment of Major Depressive Disorder (MDD) in 200 adults.
What's being tested
- High Dose Resistance Exercise Training
Intervention · BEHAVIORAL
- Low Dose Resistance Exercise Training Group
Intervention · BEHAVIORAL
Both interventions
Progressive resistance exercise training
Study details
- Official title
- Resistance Exercise to Treat Major Depression Via Cerebrovascular Mechanisms: Confirming Efficacy and Informing Precision Medicine
- Sponsor
- University of Wisconsin, Madison
- Conditions
- Major Depressive Disorder
- Enrolling
- 200 people
- Starts
- 2024-01-01
- Est. completion
- 2029-10-31
- Design
- Double-blind, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years – 65 YearsSex ALLHealthy volunteers Not acceptedYou may qualify if
- Be diagnosed with DSM-5 MDD, confirmed via Structured Clinical Interview for DSM-5 (SCID).
- Have current depressive symptoms of at least mild severity defined by the Hamilton Rating Scale of Depression 17 greater than or equal to 8 (HAMD; using the GRID-HAMD evaluated by trained, masked raters)
- Be ages 18-65
- EITHER not taking any mental health medications or seeking other mental health treatment (e.g., behavioral, psychological) OR be on a stable mental health medication and/or treatment regimen for the past 8 weeks, and intend to maintain that regimen for the duration of the study
- Safe to exercise based on physical activity screening questions or physician clearance
- Willing to be randomized to either condition
- Have a Smartphone
You can't join if
- Currently pregnant, nursing, or planning to become pregnant during the trial
- Class III+ obesity
- Diagnosed with lifetime or current Psychosis, Mania, or Bipolar Disorder, via the SCID
- Diagnosed with current Substance Use Disorder, via the SCID
- Active suicidal ideation with specific plan and intent ('5' score on Suicidal Ideation from Columbia Suicide Severity Rating Scale), which would necessitate immediate emergent care
- Exhibit behavioral disturbance (e.g., aggression, mild-moderate cognitive impairment) that would significantly interfere with study participation, as assessed by clinical research personnel
- Currently meets resistance exercise recommendations (2 days per week) for the last 8 weeks
- Self-reporting a concussion/traumatic brain injury within the last 3 months
- Having cardiovascular disease, uncontrolled hypertension, or uncontrolled diabetes
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (2)
1 openUniversity of Wisconsin - Madison
Madison, Wisconsin, United States
- Taline Jouzi · Contact608-890-0154jouzi@wisc.edu
RecruitingIowa State University
Ames, Iowa, United States
Completed
Study team
Sponsor
University of Wisconsin, Madison
Study ID 2025-0295
Principal investigator
Jacob Meyer, PhD
University of Wisconsin, Madison
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.